Symbols

CASI(Delisted)

CASI Pharmaceuticals·NASDAQ

--(--)

3.84 / 10

Netural

Fund-flow metrics are encouraging, scoring 6.67/10. Medium-sized inflows show a positive trend, hinting at underlying buying interest. Analyst coverage is limited to one ‘Strong Buy’ rating from HC Wainwright & Co., but the historical win rate for this analyst is only 0% over the recent 20 days, tempering enthusiasm. Sentiment is neutral, and overall capital movement is not yet decisively bullish.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

100%

Buy

Hold

Sell

Strong Sell

Date2025-09-03

InstitutionHC Wainwright & Co.

Times predicted3

Historical Win Rate0.0%

What is the analyst consensus for CASI?

CASI holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.84/10 (Netural).